Victor Certal

USPTO Granted Patents = 10 (Patent Applications = 6)

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 7.9

ph-index = 4

Forward Citations = 43(Granted Patents)

Location History:

Draveil, FR (2011 - 2015)
Paris, FR (2012 - 2022)

Company Filing History:

Years Active: 2011-2022

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11214541 - Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof (2022-01-04),

2. 11149031 - Substituted N-(3-fluoropropyl)-pyrrolidine compounds, processes for their preparation and therapeutic uses thereof (2021-10-19),

3. 10570090 - Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof (2020-02-25),

4. 9714221 - Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof (2017-07-25),

5. 9133168 - Pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors (2015-09-15),

6. 8993565 - (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors (2015-03-31),

7. 8791255 - (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors (2014-07-29),

8. 8507483 - 1H-pyrimidin-2-one derivatives, preparation thereof and pharmaceutical use thereof as inhibitors of AKT (PKB) phosphorylation (2013-08-13),

9. 8309721 - HSP90 inhibitory carbazole derivatives, compositions containing same and use thereof (2012-11-13),

10. 7935819 - Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors (2011-05-03),

Title: Victor Certal: Innovator in Therapeutic Compounds

Introduction

Victor Certal is a prominent inventor based in Paris, France, known for his significant contributions to the field of medicinal chemistry. With an impressive portfolio of 10 patents, he has made significant strides in developing therapeutic compounds that exhibit potential benefits in various medical applications.

Latest Patents

Certal's latest innovations include the patent for substituted 6,7-dihydro-5H-benzo[7]annulene compounds. This work outlines processes for their preparation and therapeutic uses, representing a pivotal advancement in the medicinal chemistry landscape. Additionally, he has developed substituted N-(3-fluoropropyl)-pyrrolidine compounds, disclosing their preparation and therapeutic uses as inhibitors and degraders of estrogen receptors. This patent features compounds of formula (I-A), where R1 and R2 can be a hydrogen or deuterium atom, and A can be either an oxygen or nitrogen atom. The selective estrogen receptor modulator fragment SERM-F, which consists of an aryl or heteroaryl group linked to the adjacent 'A' group, further enhances the relevance of his work.

Career Highlights

Throughout his career, Victor Certal has made notable contributions while working with established companies in the pharmaceutical industry. He has had significant roles at both Sanofi and Aventis Pharma, where his expertise in drug development has yielded groundbreaking results in therapeutic research.

Collaborations

Victor has collaborated with numerous accomplished professionals, including Frank Halley and Fabienne Thompson. Through their collective efforts, they have advanced the scientific understanding and development of innovative therapeutic compounds, contributing to the broader goals of medicine and public health.

Conclusion

Victor Certal continues to push the boundaries of pharmaceutical innovation through his research and patents. His work in developing new therapeutic compounds not only enhances treatment options for patients but also exemplifies the spirit of innovation that drives progress in the medical field. With a career marked by collaboration and creativity, Certal stands as a noteworthy figure in contemporary medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.